Introduction
Both mineralo-and glucocorticoids influence important transport and metabolic functions of the kidney, and among their proposed mechanisms of action is a direct or indirect stimulatory effect on renal sodium-and potassium-activated adenosine triphosphatase (Na-K-ATPase)' (1) (2) (3) (4) . The role of adrenal steroids in the regulation of renal Na-K-ATPase has been amply documented by ablative studies, which invariably show a substantial decline in the activity ofthe enzyme after adrenalectomy (ADX) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . However, the relative contribution of the two major classes of corticosteroids to this regulation has not been conclusively determined: Whereas some studies stress the importance of the mineralocorticoid effect (1, 2, 9, 10, 14, [17] [18] [19] , others attribute a predominant role to glucocorticoids (3, 5, 13, 20) . This controversy appears largely due to several methodologic or design limitations ofprevious reports, including determination of enzyme activity in kidney homogenates that are heterogeneous, use of synthetic corticosteroids whose renal actions may differ from that of the native hormones, and administration of supraphysiologic doses ofthe hormone that could produce nonspecific effects because of hemodynamic alterations or receptor cross-occupancy.
The recent development of sensitive methods for measuring Na-K-ATPase activity in discrete nephron segments (21, 22) and for mapping receptor distribution ofcorticosteroid hormones along the nephron (23, 24) , together with a reliable way to maintain chronically plasma aldosterone (Aldo) or corticosterone (CS) of adrenalectomized (ADX) rats at normal endogenous levels (25) , prompted us to reevaluate this issue. Combining adrenal ablation with continuous replacement of the individual hormones, we determined in the rat the respective roles of the native mineralocorticoid (Aldo) and glucocorticoid (CS) in the regulation of Na-K-ATPase in the cortical collecting tubule (CCT), a major target nephron segment for both hormones. The results indicate that physiologic replacement doses of Aldo prevent the decline of Na-K-ATPase in the CCT and restore its activity after it had been allowed to decrease maximally following ADX, whereas similar replacement ofCS was without effect. These observations suggest that under physiologic conditions renal Na-K-ATPase is under mineralocorticoid, rather than glucocorticoid, control.
Methods
The purpose ofthis study was to assess the role ofcorticosteroid hormones in maintaining renal Na-K-ATPase if given at ADX, and in restoring its activity after it was allowed to reach a nadir after adrenal ablation. The two components of this work are accordingly labeled the "maintenance" (A) and "restoration" (B) study, respectively. Duration of the experimental protocol was I wk in the former (groups I-IV, see below), and 2 wk in the latter (groups V-VII). All animals were fed a normal chow diet (Teklad 4%, Harlan Sprague Dawley, Inc., M. A. Laboratory Animals & Teklad Diets, Madison, WI) that contained 1% NaCl by weight, and were given 0.3% NaCl to drink ad lib. Doses of hormones administered in this study were shown to generate in ADX rats circulating levels similar to those of intact, nonstressed animals and to restore colonic potential difference to normal (25) .
Male 
Metabolic balance study
Animals of groups I-IV (study A) were individually placed in metabolic cages (Nalge Co., Rochester, NY) for two separate periods of 24 h (5th and 6th d after ADX). On the first, they were allowed to acclimate to the cage; food and fluid intake and the urinary excretion of sodium and potassium were determined during the 2nd d (6th d post-ADX).
Renal function
Clearance experiments were performed in rats from groups I-IV on the 7th d post-ADX. The animals were anesthetized with 100 mg/kg i.p. sodium 5-ethyl-5-( l'-methylpropyl)-2-malonylthiourea (Inactin, Promonta, Hamburg, FRG). The trachea, bladder, and one jugular vein and carotid artery were cannulated. During surgery, I ml isotonic saline (-0.5% body wt) was infused to replace estimated fluid losses. The rats were placed on heated boards and their rectal temperature was monitored with a thermistor probe (Yellow Springs Instrument Co., Yellow Springs, OH) and maintained between 370 and 380C. All solutions were administered with constant-infusion pumps (model 975, Harvard Apparatus Co. Inc., S. Natick, MA). Glomerular filtration rate (GFR) was measured as the clearance of radioactive inulin. The priming dose of [methoxy 3H]inulin (100 ,Ci/kg body wt) was followed by a sustaining infusion of isotonic saline in a volume (0.1 1 ml/min) sufficient to ensure adequate urine flow that delivered appropriate amounts of inulin (50 gCi/kg per h) to maintain constant plasma concentrations. After an equilibration period of 45 min, three urine specimens were collected in preweighed plastic tubes and four arterial blood samples were obtained for clearance measurements. At the end of the experiments the right kidney was removed and weighed, and the left kidney was perfused in situ with a collagenase-containing solution (type 1, 400 U/ml, Sigma Chemical Co., St. Louis, MO) in preparation for microdissection (see below). Concentrations of radioactive inulin (New England Nuclear, Boston, MA) in urine and serum were determined using a liquid scintillation counter (Packard Instrument Co., Inc., Downers Grove, IL). The clearance of inulin was calculated by standard formulas using urine/plasma concentration ratios and urine flows. Sodium and potassium were measured by flame photometry with lithium as the internal standard (model IL 343, Instrumentation Laboratory, Inc., Lexington, MA).
Hormone assays
Methods for the determination of plasma Aldo and CS have been described in detail elsewhere (25) . In brief, plasma CS levels were determined by the competitive protein-binding method described by Murphy (26) . Two ethanol extractions of rat plasma (0.1 ml plasma/1.0 ml ethanol) were combined, dried under nitrogen, and allowed to compete with tritiated CS (New England Nuclear) for binding sites on human corticosterone-binding globulin (CBG) at 40C. After equilibration, CBGbound CS was separated from the unbound fraction by the addition of dextran-coated charcoal, followed by centrifugation.The supernatant was decanted into scintillation fluid and the activity of [3H]CS was determined in a Packard Tri-Carb scintillation counter (Packard Instrument Co., Inc.). The concentration of CS was calculated by comparing the percent CS bound to unknowns with standards processed in the same way.
Measurement of plasma Aldo was accomplished by combining the chromatographic purification method of Biihler et al. (27) with a commercial Aldo radioimmunoassay kit (Kald-2, Diagnostic Products Corp., Los Angeles, CA). Purification of the samples before radioimmunoassays was necessary because of the relatively high cross-reactivity of the commercial Aldo antiserum with CS (manufacturer's information), and possibly with other substances occurring naturally in rat plasma. Using 
Statistical analysis
The statistical analysis was done using Student's t test for paired and nonpaired samples. When more than two groups were compared, Bonferroni inequalities were considered and a level of significance of 0.05/ n was used, n being the number of groups (28) .
Results
Maintenance study (A) Metabolic balance study (Table I) . Adrenal-intact animals gained on average 6 g/d and Aldo-replaced animals (group IV) had a similar weight gain. In contrast, ADX controls (group II) and CS-replaced (group III) rats gained only a modest amount. Sodium intake and excretion were comparable in groups I-III, and somewhat lower in group IV. Plasma Na was similar in all experimental groups. ADX, untreated animals were hyperkalemic, and both CS and Aldo replacement normalized serum potassium. Daily K excretion did not differ between the groups.
Renal function (Table II) . GFR was significantly lower in all ADX animals (groups II-IV) compared with sham-operated controls, regardless ofsteroid replacement; this finding persisted whether GFR was calculated in relation to body weight or kidney weight. Although GFR was slightly higher in Aldo-replaced than in ADX, untreated rats, the difference was not significant when factored by body or kidney weight. Both net tubular sodium reabsorption (TNa) and potassium excretion were decreased by ADX and only partially restored towards control levels by Aldo replacement, while CS replacement had only a minimal effect on these measurements.
A TPase activity (Fig. 1) . ADX led to a 52% decrease in Na-K-ATPase activity in CCT, and CS replacement (group III) failed to prevent this decrease; the enzyme activity in this group was similar to that measured in untreated ADX animals. In contrast, Aldo replacement (group IV) maintained Na-K-ATPase activity at a level not different from sham-operated controls.
Restoration study (B) Body weight, plasma electrolytes, and hormone levels (Table  III) . Weight gain was minimal in ADX animals between the seventh and fourteenth postoperative days, but both CS and (Fig. 2) . Na-K-ATPase activity in ADX rats (group V) decreased at 14 d to a level not different from that observed at 7 d (group II). CS replacement (group VI) failed to restore Na-K-ATPase activity, as it failed to maintain it when given at ADX: the level of enzyme activity in these animals was not different from that measured in untreated ADX controls. In contrast, Aldo replacement (group VII) led to a marked in- crease in Na-K-ATPase activity to levels higher than those measured in all other groups. The time couse of the restoration of enzyme activity by Aldo replacement is illustrated in Fig. 3 restored Na-K-ATPase activity fully at 24 h [data not shown].) Serum potassium decreased progressively with Aldo replacement in reciprocal fashion with the increment in Na-K-ATPase activity.
Discussion
The experiments described in this paper demonstrate that the reduction in CCT Na-K-ATPase that follows ADX can be prevented by physiologic doses of Aldo, but not by CS. Furthermore, replacement doses ofthe mineralocorticoid restored the enzyme activity when it has been allowed to decrease maximally after adrenal ablation, whereas similar treatment with the glucocorticoid hormone was without effect. These observations strongly suggest that modulation of Na-K-ATPase activity in the CCT is a putative mineralocorticoid function.
Analysis of the regulatory role of adrenocortical hormones on renal Na-K-ATPase has been complicated by several factors.
Chief among them is that for the most part the enzyme was measured in kidney homogenates that are heterogenous, only a small fraction thereof consisting of target cells of mineralocorticoid hormone. Consequently, a stimulatory effect of mineralocorticoids on their target nephron segment may be offset by a large background of enzyme activity from hormone-insensitive structures. Thus, both ourselves (Mujais, S. K., M. A. Chekal, W. J. Jones, J. P. Hayslett, and A. I. Katz, manuscript in preparation) and others (19, 29) have observed that either high physiologic or pharmacologic doses of mineralocorticoids (Aldo, 5 gg/100 g per d in the rat and deoxycorticosterone acetate, 5 mg/d in the rabbit, respectively) enhanced Na-KATPase activity only in certain subdivisions of the collecting tubule. In the present study, the CCT was selected because it is a well characterized target site for Aldo action (30) . In addition, this nephron segment contains the highest concentration of (33, 34) . The choice of CS in our study was prompted by the fact that this steroid is the natural, and possibly the sole, glucocorticoid in the rat (35) .
In many of the previous reports hormones were given in pharmacologic doses, and even when in an attempt to simulate physiologic levels the total dose was lower, administration by bolus injection probably produced transient pharmacologic levels in the circulation, and thus at the receptor sites. High concentrations of mineralocorticoids in ADX animals may lead to receptor cross-occupancy ("illicit occupancy" of glucocorticoid receptors) and thus to expression of a glucocorticoid effect and, conversely, it is possible that pharmacologic concentrations of glucocorticoids generate a mineralocorticoid effect by the same mechanism (30, 36, 37) . Furthermore, large doses of glucocorticoids increase renal blood flow and GFR above normal (37, 38) . To circumvent these difficulties we took advantage of an Adrenal ablation is associated with decreased Na-K-ATPase activity in multiple nephron segments (16, 17) . The universal nature of this decrease contrasts with the segment-specific distribution of hormone receptors, and raises the possibility that it is due to the hemodynamic consequences of the ablative procedure. Evaluation of the role of specific hormone replacement on enzyme activity, therefore, must also assess other factors that influence enzyme activity, e.g., GFR and sodium reabsorptive and potassium secretory loads (39) . In this study, sodium intake and sodium and potassium excretion were similar in all groups or, ifanything, were somewhat lower in the Aldo-replaced animals (Table I) . ADX led to a striking decrease in GFR, associated with hyperkalemia and mild hyponatremia. Both CS and Aldo replacement, whether started at ADX or 1 wk later, corrected in full or in part the plasma electrolyte abnormalities without completely restoring either the GFR, net sodium reab-2 sorption, or net potassium excretion.
The reasons why attainment of normal circulating levels of Aldo, and especially of CS, did not restore fully the GFR are not clear. However, this fact makes it possible to examine the direct effect of each steroid on tubular Na-K-ATPase, independent ofchanges in renal hemodynamics: whereas CS replacement failed to prevent the decline in enzyme activity or to restore it after ADX, physiologic replacement doses of Aldo accomplished both: When begun at ADX, it fully maintained Na-K-ATPase activity at the levels seen in adrenal-intact controls; when replacement was initiated 1 wk after ADX, enzyme activity was partially restored by 24 h, and complete restoration was achieved by 72 h3 (Fig. 3) . Maintenance and restoration of Na-K-ATPase 2. These data refer to the kidney as a whole and do not exclude a different effect on electrolyte transport in the CCT. 3. After 7 d Na-K-ATPase activity in this group was higher than in adrenal-intact rats. The explanation for this phenomenon is not apparent, but might reflect up-regulation of Aldo receptors following ADX, since in these rats circulating levels of the hormone were normal. The fact that enzyme activity was only partially restored after 24 h is consistent with our previous observations in another species, which did not document a short-term effect of Aldo on Na-K-ATPase (16) . activity by Aldo in spite of a chronic reduction in GFR suggests a direct hormonal effect on the CCT. Finally, the enhancing effect of Aldo on renal Na-K-ATPase was observed with a protocol that elicits a well-defined mineralocorticoid effect on the colon (25) while providing normal circulating levels of the hormone, which underscores the physiologic relevance of these observations. In summary, using adrenal ablation combined with selective hormone replacement and a sensitive method for measurement of Na-K-ATPase in a target nephron segment for both classes of corticosteroids, the present study indicates that under physiologic conditions Na-K-ATPase activity in rat kidney CCT is under mineralocorticoid, rather than glucocorticoid control.
